ICON8: A GCIG phase III randomised trial evaluating weekly dose- dense chemotherapy integration in first-line epithelial ovarian/fallopian tube/primary peritoneal carcinoma (EOC) treatment: Results of primary progression- free survival (PFS) analysis

Publication | Closed Access

DOI

Citations

References

2017

Year

A. Clamp, Iain A. McNeish, Andrew Dean, David Gallardo, J. Weon-Kim, Dearbhaile M. O’Donnell, Jane Hook, C. Coyle, Sarah P. Blagden, James D. Brenton,

Annals of Oncology

Gastrointestinal OncologyMedicineCancer ManagementGcig Phase IiiGynecologyCancer TreatmentOncologyRadiation OncologyGynecology OncologyOvarian Cancer